Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Illumina for Startups Home

Illumina Perspectives Blog | Author Archive

Author: Francis deSouza
2 min read
How sequencing helps solve the "unknown" of novel viral outbreaks
By Francis deSouza, CEO 13 February 2020
3 min read
Helping the heroes on the front lines of the SARS-CoV-2 battle
By Francis deSouza, CEO 18 February 2020
2 min read
Why You Should Care about Rare Disease Day
By Francis deSouza, CEO 24 February 2020
2 min read
DNA Day in the time of COVID-19
By Francis deSouza, CEO 25 April 2020
2 min read
Every voice raised against racism chips away at its power
By Francis deSouza, CEO 30 June 2020
11 min read
2020 in genomics: a global pandemic and groundbreaking scientific developments
By Francis deSouza, CEO 13 December 2020
4 min read
2021 in Genomics
By Francis deSouza, CEO 30 December 2021
Return to All Blog Articles
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2023 Illumina, Inc. All rights reserved.